Lumosa Therap 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
17 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Naldebain (dinalbuphine) / Lumosa Therap
NCT05266027: Naldebain for Pain Management After Knee Arthroplasty

Completed
4
80
RoW
Nalbuphine Sebacate (Naldebain), Placebo medication
Kaohsiung Medical University Chung-Ho Memorial Hospital
Arthropathy of Knee Joint
11/22
11/22
NCT05115955: PO Pain Management With Extended-release Dinalbuphine Sebacate in Patients Undergoing Arthroscopic Shoulder Surgery

Completed
4
76
RoW
DS group, NALDEBAIN®, Control group, Sesame oil
Tri-Service General Hospital
Anesthesiology, Orthopedic
05/24
06/24
NCT06176222: Combined Use of Naldebain® ER Injection and Precedex® After VATS

Not yet recruiting
4
70
RoW
PRECEDEX INJ★ 2ML, Dexmedetomidine, Normal saline, 0.9% Normal Saline
Kaohsiung Medical University Chung-Ho Memorial Hospital
Acute Post Operative Pain, Chronic Post Operative Pain, Postoperative Complications
12/25
03/26
NCT05825495: Postoperative Pain Management on Uvulopalatopharyngoplasty Patients

Not yet recruiting
4
78
NA
Dinalbuphine sebacate, Naldebain, Routine practice
Li-Jen Hsin
Pain, Postoperative, Obstructive Sleep Apnea-hypopnea Syndrome, Pain, Acute
04/24
05/24
NCT04962152: Naldebain and Video-assisted Thoracoscopic Surgery

Recruiting
4
60
RoW
Nalbuphine Sebacate or Sesame oil (placebo), Naldebain ER
Kaohsiung Medical University Chung-Ho Memorial Hospital
Analgesia, Nausea and Vomiting, Postoperative, Itching, Injection Site Reaction, Satisfaction, Patient
05/24
05/24
ChiCTR2100045554: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Study, to Evaluate the Efficacy and Safety of Dinalbuphine Sebacate Extended Release Injection in Patients With Postoperation Pain

Recruiting
3
120
 
Intramuscular Injection of Dinalbuphine Sebacate Extended Release Injection ;Intramuscular Injection of Placebo
Shanghai Jiaotong University School of Medicine, Renji Hospital; Shanghai Jemincare Pharmaceuticals Co., Ltd, Self-financing
Postoperation pain
 
 
EMRP-73109N, NCT04651361: Naldebain for Pain Control After Bariatric Surgery

Recruiting
2/3
60
RoW
Dinalbuphine sebacate, Naldebain ER®, Sebacoyl Dinalbuphine Ester Injection, Placebo solution
E-DA Hospital
Pain, Postoperative, Pain, Chronic, Bariatric Surgery, Obesity, Pharmacokinetics
03/22
06/22
NCT06344169: Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section

Not yet recruiting
2/3
120
NA
Sebacoyl Dinalbuphine Ester, Naldebain, Morphine
Dalin Tzu Chi General Hospital
Postsurgical Pain, Cesarean Section, Chronic Post-surgical Pain
03/26
06/26
NCT05187520: Naldebain for Control of Post-Cesarean Section Pain

Not yet recruiting
2
120
RoW
Patient-controlled epidural analgesia (PCEA), Naldebain®, Naldebain ER®, Sebacoyl Dinalbuphine Ester Injection
E-DA Hospital
Post Operative Pain, Acute, Post Operative Pain, Chronic, Cesarean Section
06/23
10/23
NCT05842733: A Novel, Potent and Non-addictive Analgesic of Combinations for Knee Replacement Moderate to Severe Pain Management

Enrolling by invitation
2
36
RoW
Naldebain, Placebo A + Tween20 and PEG400, SafeTynadol, Placebo B + Tween20 and PEG400, Naldebain + SafeTynadol, Tween20 and PEG400
Sinew Pharma Inc.
Pain, Postoperative
12/24
12/24
NCT05009771: Postoperative Pain Management of Caesarean Section

Recruiting
N/A
150
RoW
Intravenous patient-control analgesia, IV-PCA, Dinalbuphine sebacate, NALDEBAIN
Mackay Memorial Hospital
Postoperative Pain, Caesarean Section, Analgesia
04/24
07/24
NCT06397807: Postoperative Pain Management on Patients Undergoing Lung Tumor Resection

Not yet recruiting
N/A
400
NA
Dinalbuphine sebacate, Naldebain, Analgesic injectables, A.I., Enteral analgesics, E.A.
China Medical University Hospital
Postoperative Pain, Lung Cancer, Lung Tumor
03/26
05/26
NCT05446311: Naldebain® Extended-release Injection After Cesarean Section in Pain Management

Not yet recruiting
N/A
20
NA
Dinalbuphine sebacate, NALDEBAIN
Tri-Service General Hospital
Post Operative Pain, Caesarean Section, Analgesia
12/22
12/22
LT3001 / Lumosa Therap
BRIGHT, NCT05403866: A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS Subjects

Not yet recruiting
2
200
NA
LT3001 Drug Product, Placebo
Lumosa Therapeutics Co., Ltd.
Acute Ischemic Stroke
03/24
03/24
NCT05198323: A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT

Not yet recruiting
2
66
NA
LT3001 Drug Product, Placebo
Lumosa Therapeutics Co., Ltd.
Acute Ischemic Stroke
04/24
04/24
NCT05686642: Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

Recruiting
2
300
RoW
LT3001 Drug:high dose, Placebo, LT3001 Drug:low dose
Shanghai Pharmaceuticals Holding Co., Ltd
Acute Ischemic Stroke
12/25
12/25
NCT04809818: A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects

Recruiting
1
64
US
LT3001 drug product, LT3001 injection, Placebo, Placebo of LT3001 drug product, Aspirin, Aspirin tablet, Clopidogrel, Clopidogrel tablet, Apixaban, Eliquis®, Dabigatran, Pradaxa®
Lumosa Therapeutics Co., Ltd.
Acute Ischemic Stroke
07/21
10/21
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Naldebain (dinalbuphine) / Lumosa Therap
NCT05266027: Naldebain for Pain Management After Knee Arthroplasty

Completed
4
80
RoW
Nalbuphine Sebacate (Naldebain), Placebo medication
Kaohsiung Medical University Chung-Ho Memorial Hospital
Arthropathy of Knee Joint
11/22
11/22
NCT05115955: PO Pain Management With Extended-release Dinalbuphine Sebacate in Patients Undergoing Arthroscopic Shoulder Surgery

Completed
4
76
RoW
DS group, NALDEBAIN®, Control group, Sesame oil
Tri-Service General Hospital
Anesthesiology, Orthopedic
05/24
06/24
NCT06176222: Combined Use of Naldebain® ER Injection and Precedex® After VATS

Not yet recruiting
4
70
RoW
PRECEDEX INJ★ 2ML, Dexmedetomidine, Normal saline, 0.9% Normal Saline
Kaohsiung Medical University Chung-Ho Memorial Hospital
Acute Post Operative Pain, Chronic Post Operative Pain, Postoperative Complications
12/25
03/26
NCT05825495: Postoperative Pain Management on Uvulopalatopharyngoplasty Patients

Not yet recruiting
4
78
NA
Dinalbuphine sebacate, Naldebain, Routine practice
Li-Jen Hsin
Pain, Postoperative, Obstructive Sleep Apnea-hypopnea Syndrome, Pain, Acute
04/24
05/24
NCT04962152: Naldebain and Video-assisted Thoracoscopic Surgery

Recruiting
4
60
RoW
Nalbuphine Sebacate or Sesame oil (placebo), Naldebain ER
Kaohsiung Medical University Chung-Ho Memorial Hospital
Analgesia, Nausea and Vomiting, Postoperative, Itching, Injection Site Reaction, Satisfaction, Patient
05/24
05/24
ChiCTR2100045554: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Study, to Evaluate the Efficacy and Safety of Dinalbuphine Sebacate Extended Release Injection in Patients With Postoperation Pain

Recruiting
3
120
 
Intramuscular Injection of Dinalbuphine Sebacate Extended Release Injection ;Intramuscular Injection of Placebo
Shanghai Jiaotong University School of Medicine, Renji Hospital; Shanghai Jemincare Pharmaceuticals Co., Ltd, Self-financing
Postoperation pain
 
 
EMRP-73109N, NCT04651361: Naldebain for Pain Control After Bariatric Surgery

Recruiting
2/3
60
RoW
Dinalbuphine sebacate, Naldebain ER®, Sebacoyl Dinalbuphine Ester Injection, Placebo solution
E-DA Hospital
Pain, Postoperative, Pain, Chronic, Bariatric Surgery, Obesity, Pharmacokinetics
03/22
06/22
NCT06344169: Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section

Not yet recruiting
2/3
120
NA
Sebacoyl Dinalbuphine Ester, Naldebain, Morphine
Dalin Tzu Chi General Hospital
Postsurgical Pain, Cesarean Section, Chronic Post-surgical Pain
03/26
06/26
NCT05187520: Naldebain for Control of Post-Cesarean Section Pain

Not yet recruiting
2
120
RoW
Patient-controlled epidural analgesia (PCEA), Naldebain®, Naldebain ER®, Sebacoyl Dinalbuphine Ester Injection
E-DA Hospital
Post Operative Pain, Acute, Post Operative Pain, Chronic, Cesarean Section
06/23
10/23
NCT05842733: A Novel, Potent and Non-addictive Analgesic of Combinations for Knee Replacement Moderate to Severe Pain Management

Enrolling by invitation
2
36
RoW
Naldebain, Placebo A + Tween20 and PEG400, SafeTynadol, Placebo B + Tween20 and PEG400, Naldebain + SafeTynadol, Tween20 and PEG400
Sinew Pharma Inc.
Pain, Postoperative
12/24
12/24
NCT05009771: Postoperative Pain Management of Caesarean Section

Recruiting
N/A
150
RoW
Intravenous patient-control analgesia, IV-PCA, Dinalbuphine sebacate, NALDEBAIN
Mackay Memorial Hospital
Postoperative Pain, Caesarean Section, Analgesia
04/24
07/24
NCT06397807: Postoperative Pain Management on Patients Undergoing Lung Tumor Resection

Not yet recruiting
N/A
400
NA
Dinalbuphine sebacate, Naldebain, Analgesic injectables, A.I., Enteral analgesics, E.A.
China Medical University Hospital
Postoperative Pain, Lung Cancer, Lung Tumor
03/26
05/26
NCT05446311: Naldebain® Extended-release Injection After Cesarean Section in Pain Management

Not yet recruiting
N/A
20
NA
Dinalbuphine sebacate, NALDEBAIN
Tri-Service General Hospital
Post Operative Pain, Caesarean Section, Analgesia
12/22
12/22
LT3001 / Lumosa Therap
BRIGHT, NCT05403866: A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS Subjects

Not yet recruiting
2
200
NA
LT3001 Drug Product, Placebo
Lumosa Therapeutics Co., Ltd.
Acute Ischemic Stroke
03/24
03/24
NCT05198323: A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT

Not yet recruiting
2
66
NA
LT3001 Drug Product, Placebo
Lumosa Therapeutics Co., Ltd.
Acute Ischemic Stroke
04/24
04/24
NCT05686642: Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

Recruiting
2
300
RoW
LT3001 Drug:high dose, Placebo, LT3001 Drug:low dose
Shanghai Pharmaceuticals Holding Co., Ltd
Acute Ischemic Stroke
12/25
12/25
NCT04809818: A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects

Recruiting
1
64
US
LT3001 drug product, LT3001 injection, Placebo, Placebo of LT3001 drug product, Aspirin, Aspirin tablet, Clopidogrel, Clopidogrel tablet, Apixaban, Eliquis®, Dabigatran, Pradaxa®
Lumosa Therapeutics Co., Ltd.
Acute Ischemic Stroke
07/21
10/21

Download Options